Yes, diltiazem is one of the most commonly used medications for atrial fibrillation (AFib). It works by slowing the heart rate rather than correcting the irregular rhythm itself, making it a core “rate control” drug. Both American and European cardiology guidelines list it as a standard of care for managing AFib.
How Diltiazem Works in AFib
During atrial fibrillation, the upper chambers of the heart fire chaotic electrical signals. Many of those signals pass through the atrioventricular (AV) node, the gateway between the upper and lower chambers, causing the lower chambers to beat too fast. Diltiazem blocks calcium channels in the AV node, which slows electrical conduction through that gateway and makes it less responsive to the rapid signals coming from above. The result is a lower, more manageable heart rate even though the underlying irregular rhythm may continue.
This is an important distinction. Diltiazem does not “fix” AFib. It controls the speed at which your heart beats during an episode, which relieves symptoms like pounding in the chest, shortness of breath, and lightheadedness. Doctors typically aim for a resting heart rate below 100 beats per minute, or at least a 20% drop from baseline.
How It Compares to Beta-Blockers
Beta-blockers like metoprolol are the other major class of rate-control drugs for AFib. Both are considered first-line options, but head-to-head data favors diltiazem in acute situations. A meta-analysis of 14 studies involving 1,732 emergency department and ICU patients found that IV diltiazem was nearly twice as likely to achieve the target heart rate compared to IV metoprolol. When the analysis was restricted to the three randomized controlled trials alone, the advantage was even more pronounced, with diltiazem roughly eight times more likely to hit the rate-control target. Heart rate reductions were also greater at 5, 10, and 15 minutes with diltiazem, and there was no significant difference in blood pressure drops or adverse events between the two drugs.
That said, beta-blockers have their own advantages. They’re preferred when AFib coexists with heart failure that involves a weakened pump (reduced ejection fraction), a situation where diltiazem can actually cause harm. So the choice between the two often depends on what else is going on with your heart.
IV Diltiazem for Rapid Heart Rates
When someone arrives at the emergency department with AFib and a dangerously fast heart rate, diltiazem is frequently the first drug given through an IV. The typical initial dose is based on body weight, with about 20 mg being standard for an average-sized adult, delivered over two minutes. If the heart rate doesn’t come down enough within 15 minutes, a second, slightly larger dose (around 25 mg) can be given.
Once the heart rate is under control, a continuous IV drip often follows, starting at a low rate and adjusted upward as needed. This buys time to transition to an oral medication. IV infusions are generally limited to 24 hours because longer durations haven’t been well studied. Throughout this process, your heart rhythm and blood pressure are monitored continuously.
Long-Term Oral Use
For ongoing rate control, diltiazem comes in extended-release capsules taken once daily. Most people start at 120 to 180 mg per day, with the dose adjusted over time based on how well the heart rate stays controlled during normal activities and rest. Some people need higher doses, and your prescriber will titrate gradually.
The transition from IV to oral diltiazem usually happens in the hospital. Studies have shown that heart rate control is maintained during this switch, so there isn’t typically a gap where your rate spikes back up.
Who Should Not Take Diltiazem
Diltiazem is not appropriate for everyone with AFib. The most important restriction involves heart failure with reduced ejection fraction, a condition where the heart muscle is too weak to pump blood efficiently. In these patients, diltiazem is associated with worsening heart failure. Beta-blockers or other strategies are used instead.
Other situations where diltiazem is avoided include:
- Very low blood pressure or cardiogenic shock, since diltiazem can lower blood pressure further
- Acute heart attack with fluid in the lungs, where the added cardiac depression can be dangerous
- Certain pre-existing conduction problems, such as significant AV block, because diltiazem slows conduction through the very pathway that’s already impaired
Your doctor will check for these issues before starting treatment. If you have AFib but your heart pumps normally, diltiazem is generally a safe and effective option.
Common Side Effects
Most people tolerate diltiazem well, but side effects are possible. Swelling of the ankles, feet, or lower legs is one of the more noticeable ones, caused by the drug’s effect on blood vessels. Some people experience dizziness or lightheadedness, especially when standing up quickly, because diltiazem lowers blood pressure. Headache, fatigue, and nausea occur less frequently.
A heart rate that drops too low (bradycardia) is something to watch for, particularly if you’re also taking other medications that slow the heart. If you notice persistent dizziness, unusual fatigue, or feel like your heart is beating very slowly, that’s worth bringing up with your provider. Dose adjustments usually resolve the issue.
Rate Control vs. Rhythm Control
Diltiazem falls squarely in the rate-control category. It doesn’t attempt to restore a normal heart rhythm. For some people, especially those with persistent symptoms despite good rate control, doctors may pursue a rhythm-control strategy instead, using different medications or procedures like electrical cardioversion or catheter ablation to restore a regular heartbeat. In many cases, rate control and rhythm control are used together, with diltiazem keeping the heart rate manageable while other treatments address the rhythm itself.
For people whose symptoms improve once their heart rate is controlled, diltiazem alone may be all that’s needed on an ongoing basis. The decision between rate control and rhythm control is individualized and depends on factors like how often AFib episodes occur, how severe symptoms are, and the size and structure of your heart.